Novel Combination Cancer Immunotherapy Summit 2024
Evvnt Promotion / evvnt
Archive
15.10.2024 - 17.10.2024 Sheraton Mission Valley San Diego Hotel, 1433 Camino del Rio South, 92108 San Diego, California, USA
Time: 9:00 AM - 4:00 PM
Conference themes
Welcome to the Novel Combination Cancer Immunotherapy Summit - Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond
Welcome to the Novel Combination Cancer Immunotherapy Summit - Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond
Professional congress organizer (PCO)
Hanson Wade Group
Hanson Wade Group
Notes
URL:
Brochure: https://go.evvnt.com/2511263-2?pid=4832
Speakers: Michael Chisamore, Executive Director, Clinical Research, Merck and Co, Raj Ganesan, Executive Director, Oncology, Amgen , Yuanming Xu, Associate Director, Pfizer, and more
URL:
Brochure: https://go.evvnt.com/2511263-2?pid=4832
Speakers: Michael Chisamore, Executive Director, Clinical Research, Merck and Co, Raj Ganesan, Executive Director, Oncology, Amgen , Yuanming Xu, Associate Director, Pfizer, and more
Enquiries and Registration:
https://go.evvnt.com/2511263-1?pid=4832
Ms. Nell Sydenham
Oncology
Languages
English
English
Congress fees
USD 1899.00 - USD 3997.00
USD 1899.00 - USD 3997.00
Participants expected
1000 - 1000
1000 - 1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
